| abstract |
The present invention comprises a LYPD1 (LY6/PLAUR domain containing 1) gene expression inhibitor, a LYPD1 protein activity inhibitor, or a mixture thereof as an active ingredient, a pharmaceutical composition for the prevention or treatment of cancer, the level of LYPD1 gene mRNA or a protein thereof A composition for diagnosis of cancer comprising an agent for measuring, a kit for diagnosis of cancer comprising the composition for diagnosis, and a method of providing information for diagnosis of cancer by measuring the level of mRNA of the LYPD1 gene or a protein thereof, or a method of screening a cancer therapeutic agent It is about. |